Discovery of new orally effective analgesic and anti-inflammatory hybrid furoxanyl N-acylhydrazone derivatives.

Abstract : We report the design, the synthesis and the biological evaluation of the analgesic and anti-inflammatory activities of furoxanyl N-acylhydrazones (furoxanyl-NAH) by applying molecular hybridization approach. Hybrid compounds with IL-8-release inhibition capabilities were identified. Among them, furoxanyl-NAH, 17, and benzofuroxanyl-derivative, 24, together with furoxanyl-NAH derivative, 31, without IL-8 inhibition displayed both orally analgesic and anti-inflammatory activities. These hybrid derivatives do not have additional LOX- or COX-inhibition activities. For instance, LOX-inhibition by furoxanyl-NAH derivative, 42, emerged as a structural lead to develop new inhibitors. The lack of mutagenicity of the active derivatives 17, 31, and 42, allow us to propose them as candidates for further clinical studies. These results confirmed the success in the exploitation of hybridization strategy for identification of novel N-acylhydrazones (NAH) with optimized activities.
Document type :
Journal articles
Complete list of metadatas

https://hal-riip.archives-ouvertes.fr/pasteur-00686608
Contributor : Mariella Botta <>
Submitted on : Tuesday, April 10, 2012 - 4:41:15 PM
Last modification on : Thursday, June 20, 2019 - 9:52:06 AM

Identifiers

Collections

Citation

Paola Hernández, Mauricio Cabrera, María Laura Lavaggi, Laura Celano, Inés Tiscornia, et al.. Discovery of new orally effective analgesic and anti-inflammatory hybrid furoxanyl N-acylhydrazone derivatives.. Bioorganic and Medicinal Chemistry, Elsevier, 2012, 20 (6), pp.2158-71. ⟨10.1016/j.bmc.2012.01.034⟩. ⟨pasteur-00686608⟩

Share

Metrics

Record views

144